Kadcyla
Kadcyla Products are primarily used for
Breast cancer, Metastatic breast cancer
About Kadcyla Products
Uses of Kadcyla Products
Ado-trastuzumab emtansine is used in the treatment of breast cancer and metastatic breast cancer. It is used to treat certain types of breast cancer (human epidermal growth factor receptor 2, HER-2) which have spread to other organs and have not responded to other cancer medicines.
Kadcyla Products side effects
Common
Side Effects of Kadcyla are Tiredness, Nausea, Musculoskeletal (bone, muscle or joint) pain, Bleeding, Low blood platelets, Headache, Liver disorder, Constipation, Nosebleeds.
How Kadcyla Products work
Ado-trastuzumab emtansine is an anti-cancer medicine. It binds to HER2 receptors on breast cancer cells and flags the cancer cells for destruction by the body's immune system. It also goes into the cancer cells to release a chemotherapy medicine (emtansine) and stop them from growing and dividing.
Patient Concerns about Kadcyla Products
Frequently asked questions about Kadcyla Products
Frequently asked questions about Ado-trastuzumab emtansine
Q. What is the use of Kadcyla 100mg Injection?
Kadcyla 100mg Injection is used to treat HER2-positive breast cancer that has spread to other parts of the body (metastatic breast cancer) after prior treatment with trastuzumab and a taxane.
Q. How is Kadcyla 100mg Injection different?
Kadcyla 100mg Injection is a conjugate of the HER2 directed trastuzumab and a highly toxic microtubule-targeted drug (emtansine). Thus it is made up of 2 cancer-fighting agents in 1 medicine- The monoclonal antibody trastuzumab and a chemotherapy emtansine. Kadcyla 100mg Injection brings chemotherapy medicine (emtansine) into HER2-positive cells and kills them. It is designed to cause less harm to normal cells.
Products for Kadcyla
MRP
₹155585
MRP
₹248937